Microbot Medical Inc. Files 8-K with Financials
Ticker: MBOT · Form: 8-K · Filed: Apr 24, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, corporate-update
TL;DR
Microbot Medical filed an 8-K on 4/24/24 - check financials and exhibits.
AI Summary
Microbot Medical Inc. filed an 8-K on April 24, 2024, reporting on various events including financial statements and exhibits. The company, formerly known as Cytotherapeutics Inc./DE and StemCells Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector.
Why It Matters
This filing provides an update on Microbot Medical Inc.'s corporate activities and financial status, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, primarily containing financial statements and exhibits, with no immediate indication of significant new risks or material adverse events.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- Cytotherapeutics Inc./DE (company) — Former company name
- StemCells Inc. (company) — Former company name
- April 24, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on various events, including Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, as of April 24, 2024.
What are the former names of Microbot Medical Inc.?
Microbot Medical Inc. was formerly known as StemCells Inc. and prior to that, Cytotherapeutics Inc./DE.
In which state is Microbot Medical Inc. incorporated?
Microbot Medical Inc. is incorporated in Delaware.
What is the principal executive office address for Microbot Medical Inc.?
The principal executive office address for Microbot Medical Inc. is 288 Grove Street, Suite 388, Braintree, MA 02184.
What is the SIC code for Microbot Medical Inc.?
The Standard Industrial Classification (SIC) code for Microbot Medical Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-04-24 16:52:38
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 220KB
- ex99-1_002.jpg (GRAPHIC) — 715KB
- ex99-1_003.jpg (GRAPHIC) — 470KB
- ex99-1_004.jpg (GRAPHIC) — 219KB
- ex99-1_005.jpg (GRAPHIC) — 255KB
- ex99-1_006.jpg (GRAPHIC) — 226KB
- ex99-1_007.jpg (GRAPHIC) — 265KB
- ex99-1_008.jpg (GRAPHIC) — 229KB
- ex99-1_009.jpg (GRAPHIC) — 315KB
- ex99-1_010.jpg (GRAPHIC) — 312KB
- ex99-1_011.jpg (GRAPHIC) — 215KB
- ex99-1_012.jpg (GRAPHIC) — 256KB
- ex99-1_013.jpg (GRAPHIC) — 202KB
- ex99-1_014.jpg (GRAPHIC) — 227KB
- ex99-1_015.jpg (GRAPHIC) — 241KB
- 0001493152-24-015810.txt ( ) — 6242KB
- mbot-20240424.xsd (EX-101.SCH) — 3KB
- mbot-20240424_lab.xml (EX-101.LAB) — 33KB
- mbot-20240424_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely
Item 8.01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely historical (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "intends," "would," "could" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, regulatory milestones. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this Form 8-K, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Although the Company believes that the beliefs, plans, expectations and intentions contained in this Form 8-K are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the Company's reports and statements filed from time-to-time with the Securities and Exchange Commission. Item 9.01. Financial (d) Exhibits Exhibit Number Description 99.1 Presentation Materials 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: April 24, 2024